4-aminopyridine has been researched along with Facio-Scapulo-Humeral Dystrophy in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gene analysis for congenital myasthenic syndrome (CMS) revealed a new mutation in the DOK7 gene; the diagnosis of CMS was confirmed." | 1.40 | [Beneficial effects of 3,4-diaminopyridine in a 26-year-old woman with DOK7 congenital myasthenic syndrome who was originally diagnosed with facioscapulohumeral dystrophy]. ( Mori-Yoshimura, M; Murata, M; Nakata, T; Nishikawa, A; Ohno, K; Okamoto, T; Oya, Y, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nishikawa, A | 1 |
| Mori-Yoshimura, M | 1 |
| Okamoto, T | 1 |
| Oya, Y | 1 |
| Nakata, T | 1 |
| Ohno, K | 1 |
| Murata, M | 1 |
1 other study available for 4-aminopyridine and Facio-Scapulo-Humeral Dystrophy
| Article | Year |
|---|---|
[Beneficial effects of 3,4-diaminopyridine in a 26-year-old woman with DOK7 congenital myasthenic syndrome who was originally diagnosed with facioscapulohumeral dystrophy].
Topics: 4-Aminopyridine; Adult; Amifampridine; Diagnosis, Differential; Female; Humans; Menstrual Cycle; Mus | 2014 |